Windlas Biotech one of the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO) industry in India has appointed Shailendra Rastogi as a Chief Business Officer (CBO). 

He would be responsible for handling CDMO, export, API and CRAMS business development for the company.

Prior to joining Windlas Biotech, he was associated with Mehta API Private Ltd., as an Associate Vice President (AVP) - Business Development. Prior to that he was associated with GVK Biosciences Pvt. Ltd., Ind Swift laboratories, Parabolic Drugs, Syngene International Alembic, Merck and AIMIL. at various capacities in sales and business development.

He has over 22 years of experience in pharmaceutical sales & business development and has done his MBA - Marketing from CSJM University, Kanpur; MSc - Chemistry from Lucknow University; and Bachelor of Science from Lucknow University.

“With his rich experience and a long track record of working with leading pharmaceutical companies, Shailendra brings in lots of expertise and fresh insights to the table. His appointment has further strengthened the senior management team and would further sharpen the focus on strategic business development. I congratulate him on his new role and look forward to working with him to achieve our long term vision and goals,” said Hitesh Windlass, Managing Director, Windlas Biotech.